Publications – Medicines related conversations: changes to informed consent

· Medicines Use and Safety Team

For many years the accepted practice around informed consent to treatment, including medication, was based on  the “Bolam” test.  This changed after the recent case of “Montgomery ” and informed consent now requires patients to be  given information on risks, including medicines risks, that are  material to them and that they are offered reasonable alternatives.

MUS Team members have collaborated with legal experts to publish a number of articles relevant to pharmacy practitioners who consult with patients about medicines.  These publications provide insight and guidance to help pharmacy practitioners conducting  “Montgomery compliant” consultations.